al altomari

5 stories · following the connections

Business

Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition

By Nasdaq OMXMar 14, 2018, 11:45 AM UTC

Business

Agile Therapeutics Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 6, 2017, 9:20 PM UTC

Business

Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy

By Nasdaq OMXOct 10, 2017, 10:39 PM UTC

Business

Agile Therapeutics Announces Proposed Offering of Common Stock

By Nasdaq OMXAug 2, 2017, 8:06 PM UTC

Business

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®

By Nasdaq OMXJun 27, 2017, 12:00 PM UTC